Brawn Biotech Ltd (530207) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530207 | NSE: | Trading | Small Cap

Brawn Biotech Share Price

20 0.00 0.00%
as on 04-Dec'25 16:59

Brawn Biotech Ltd (530207) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530207 | NSE: | Trading | Small Cap

DeciZen - make an informed investing decision on Brawn Biotech

Based on:

M-Cap below 100cr DeciZen not available

Brawn Biotech stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
6 Cr.
52-wk low:
15.5
52-wk high:
26.1

Is Brawn Biotech Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Brawn Biotech: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Brawn Biotech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 26.4%29%27.8%23%9.7%-3.6%-25.7%-5.9%-26.1%-42.6%-
Value Creation
Index
0.91.11.00.7-0.3-1.3-2.8-1.4-2.9-4.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 46.960.655.865.249.6358.622.216.513.517
Sales YoY Gr.-29.2%-7.9%16.9%-23.9%-29.5%-75.4%157.9%-25.8%-18.3%-
Adj EPS 3.33.34.24.11.8-2.5-5.5-2.9-4.1-5.8-2.1
YoY Gr.-0.3%26.3%-1%-57.7%-241.1%NANANANA-
BVPS (₹) 18.423.125.428.930.929.324.12116.911.212.4
Adj Net
Profit
111.31.20.5-0.7-1.7-0.9-1.2-1.7-1
Cash Flow from Ops. 0.11.4-1.50.2-0.100.20.3-00.1-
Debt/CF from Ops. 2.4000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -12.9%-23%16%-18.3%
Adj EPS -206.5%-227.1%NANA
BVPS-5.4%-18.3%-22.5%-33.6%
Share Price -8.5% -1% 2.6% -5.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
18.915.917.215.35.9-8.2-20.6-12.8-21.8-41.3-17.6
Op. Profit
Mgn %
3.22.13.51.81.5-1.7-23.3-1.4-8.9-13.2-4.6
Net Profit
Mgn %
2.11.62.31.91.1-2.1-19.1-3.9-7.5-12.9-3.7
Debt to
Equity
00000000000
Working Cap
Days
10585120122152171545214298443272
Cash Conv.
Cycle
283132274670274579918594

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Brawn Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) -2.1 -
TTM Sales (₹ Cr.) 16.8 -
BVPS (₹.) 12.4 -
Reserves (₹ Cr.) 1 -
P/BV 1.62 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 15.46 / 26.05
All Time Low / High (₹) 0.40 / 95.60
Market Cap (₹ Cr.) 6
Equity (₹ Cr.) 3
Face Value (₹) 10
Industry PE 36.9

Management X-Ray of Brawn Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Brawn Biotech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Brawn Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales46.8860.5555.7865.1849.6234.988.6222.2316.4913.46
Operating Expenses 45.4559.3153.8264.0148.8835.5710.6322.5317.9715.24
Manufacturing Costs0.200.060.060.081.281.410.190.340.200.12
Material Costs40.5252.1948.8558.5042.1030.026.5919.1814.3611.93
Employee Cost 1.861.982.983.023.082.361.801.401.401.13
Other Costs 2.865.081.932.412.411.782.041.622.012.06
Operating Profit 1.441.241.961.170.74-0.60-2.01-0.30-1.47-1.77
Operating Profit Margin (%) 3.1%2.0%3.5%1.8%1.5%-1.7%-23.3%-1.4%-8.9%-13.2%
Other Income 0.010.620.090.740.170.3100.010.090.09
Interest 0.110.070.060.070.050.040.060.010.060
Depreciation 0.030.030.030.030.030.030.050.110.100.11
Exceptional Items 0000000000
Profit Before Tax 1.301.761.961.810.82-0.36-2.12-0.41-1.54-1.80
Tax 0.360.360.680.470.230.19-0.470.46-0.30-0.06
Profit After Tax 0.951.391.281.330.59-0.55-1.64-0.87-1.25-1.74
PAT Margin (%) 2.0%2.3%2.3%2.0%1.2%-1.6%-19.1%-3.9%-7.6%-12.9%
Adjusted EPS (₹)3.24.64.34.42.0-1.8-5.5-2.9-4.2-5.8
Dividend Payout Ratio (%)32%32%23%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 5.536.927.638.669.268.807.226.315.073.36
Share Capital 3333333333
Reserves 2.533.924.635.666.265.794.223.312.060.36
Minority Interest0000000000
Debt0.05000000000
Long Term Debt0.05000000000
Short Term Debt0000000000
Trade Payables4.956.8211.2310.358.592.664.056.475.678.24
Others Liabilities 3.403.253.633.452.372.271.891.593.398.37
Total Liabilities 13.9316.9822.4922.4520.2213.7213.1614.3714.1319.97

Fixed Assets

Gross Block0.320.360.360.360.380.380.670.770.781.02
Accumulated Depreciation0.080.100.140.170.200.240.290.400.450.56
Net Fixed Assets 0.240.250.220.190.180.140.390.370.330.46
CWIP 0000000000
Investments 0.03000000000
Inventories0.500.370.350.340.390.264.724.796.0210.47
Trade Receivables9.2013.0215.0516.46159.282.815.323.883.41
Cash Equivalents 0.1720.400.540.400.400.220.440.400.20
Others Assets 3.791.346.474.924.263.655.023.453.505.43
Total Assets 13.9316.9822.4922.4520.2213.7213.1614.3714.1319.97

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.051.37-1.540.21-0.080.030.190.32-0.030.05
PBT 1.301.761.961.810.82-0.36-2.12-0.41-1.54-1.80
Adjustment 0.132.200.090.150.100.150.190.070.060.16
Changes in Working Capital -1.02-1.83-2.31-0.93-0.760.512.120.651.461.69
Tax Paid -0.36-0.76-1.29-0.82-0.23-0.2800.0100
Cash Flow From Investing Activity -0.080.57-0-0-0.020-0.30-0.10-0.01-0.24
Capex 0-0.03-0-0-0.020-0.30-0.10-0.01-0.24
Net Investments 0000000000
Others -0.080.6100000000
Cash Flow From Financing Activity -0.05-0.11-0.06-0.06-0.05-0.04-0.06-0.01-0-0
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0.05-0.0500000000
Interest Paid -0.10-0.07-0.06-0.06-0.050-0.06-0.01-0-0
Dividend Paid 0000000000
Others 00000-0.040000
Net Cash Flow -0.081.83-1.600.15-0.14-0-0.170.21-0.04-0.20

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)18.1522.3917.6216.376.6-6.1-20.53-12.83-21.93-41.3
ROCE (%)26.3929.0427.7523.039.74-3.57-25.66-5.94-26.12-42.59
Asset Turnover Ratio3.363.922.832.92.332.060.641.611.160.79
PAT to CFO Conversion(x)0.050.99-1.20.16-0.14N/AN/AN/AN/AN/A
Working Capital Days
Receivable Days726792881161272566710299
Inventory Days63223310578120223
Payable Days534167678268186100154213

Brawn Biotech Ltd Stock News

Brawn Biotech Ltd FAQs

The current trading price of Brawn Biotech on 04-Dec-2025 16:59 is ₹20.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2025 the market cap of Brawn Biotech stood at ₹6.00.
The latest P/E ratio of Brawn Biotech as of 03-Dec-2025 is 0.00.
The latest P/B ratio of Brawn Biotech as of 03-Dec-2025 is 1.62.
The 52-week high of Brawn Biotech is ₹26.05 and the 52-week low is ₹15.46.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Brawn Biotech is ₹16.79 ( Cr.) .

About Brawn Biotech Ltd

Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company’s loan license basis. The company is located in New Delhi, India.

Business Profile:

The company involves in the manufacture, contract manufacture, and supply of pharmaceutical products. It is basically engages in the manufacture of tablets, capsules, and oral syrups.

Products of the company

Company's products are made under various categories namely Analgesics, Antibiotics, Anti Tuberculosis, Anti-inflammatory, Antipyretic, Anti Malarial, B Complex and Amino Acids, Cardiovascular drugs, Antiphyscotropic drugs, Tranquilizers, Antacids.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×